The Freedom to Heal Act of 2025 aims to create a special registration process for doctors who want to administer certain investigational drugs classified as schedule I under the Controlled Substances Act. This legislation is designed to enhance access to potentially life-saving treatments for patients who have exhausted other options, in line with the Federal Right to Try law. The key provisions of this act outline a clear process for physicians to obtain registration to administer eligible investigational drugs.